Archive · 2 Jul 2025
IIT-BHU Bioengineers Develop Anti-Clotting Nanoparticles
Scientists at IIT-BHU have created tiny particles called nanoparticles that can stop blood from clotting.
These particles use a special ingredient that helps keep blood flowing smoothly.
They can keep blood from clumping up for two days, which is helpful for storing blood for transfusions.
These nanoparticles also work in mice by preventing clots and improving blood flow in tubes.
They do this by stopping a protein called fibrin from forming.
This new technology could lead to better ways to prevent and treat blood clots in the future.
Bioengineers at IIT-BHU developed nanoparticles to prevent blood clotting.
The nanoparticles, using potassium ferric oxalate, act as an antidote for thrombotic disorders.
They preserve blood in a liquid state for 48 hours, aiding blood collection and storage.
The nanoparticles prevent clot formation in mice and improve blood flow in coated catheters.
KFeOx-NPs work by binding to calcium ions, preventing fibrin formation in blood.
- Who
- Bioengineers at IIT-BHU.
- What
- Bioengineers developed nanoparticles to prevent blood clotting.
- When
- Not explicitly stated in the article.
- Where
- Indian Institute of Technology-BHU in Uttar Pradesh.
- Why
- To prevent blood clotting and treat thrombotic disorders.
- Developed By
- IIT-BHU Bioengineers
- Type
- Nanoparticles
- Function
- Prevent Blood Clotting
- Key Component
- Potassium ferric oxalate (KFeOx-NPs)
- Benefit
- Preserves blood for 48 hours
- Mechanism
- Binds to calcium ions, preventing fibrin formation